Výsledky vyhledávání - "Franco, Iuliano"

Akademický článek

Impact of age on the outcome of patients with chronic myeloid leukemia in late chronic phase: results of a phase II study of the GIMEMA CML Working Party

Autor: Gianantonio Rosti, Ilaria Iacobucci, Simona Bassi, Fausto Castagnetti, Marilina Amabile, Daniela Cilloni, Angela Poerio, Simona Soverini, Francesca Palandri, Giovanna Rege Cambrin, Franco Iuliano, Giuliana Alimena, Roberto Latagliata, Nicoletta Testoni, Fabrizio Pane, Giuseppe Saglio, Michele Baccarani, Giovanni Martinelli

Publikováno v: Haematologica, Vol 92, Iss 1 (2007)

To assess the effect of age on response and compliance to treatment in patients with chronic myeloid leukemia (CML) we performed a sub-analysis within a phase II trial of the GIMEMA CML Working Party (CML/002/STI571). Since the WHO cut-off age to def

Externí odkaz: https://doaj.org/article/d272a4f02ce5470480a35fbf92dd620b

Zobrazit plný text záznamu

Differences among young adults, adults and elderly chronic myeloid leukemia patients

Autor: D. Ielo, Mario Cazzola, A. De Vivo, Mario Petrini, G. Fioritoni, Simona Sica, Fausto Castagnetti, B. Falini, Miriam Fogli, Agostino Cortelezzi, C. Viganò, Giuliana Alimena, Maurizio Musso, G. Spinosa, Flavia Salvi, Giancarlo Latte, Michele Pizzuti, Nicola Cantore, D. Luzzi, B. Ronci, Francesco Merli, Mario Boccadoro, Diamante Turri, Monica Bocchia, Patrizia Tosi, A. M. Carella, Simona Luatti, G. Semenzato, Mariella Grasso, Nicoletta Testoni, Giovanni Martinelli, Ester Pungolino, Giuseppe Tagariello, A. Russo Rossi, Simona Soverini, Francesca Ronco, Franco Iuliano, Giovanni Rosti, Alberto Bosi, Tamara Intermesoli, Dario Ferrero, Sara Galimberti, Giovanna Rege-Cambrin, Ferdinando Porretto, Sabina Russo, Roberto Latagliata, Pellegrino Musto, E. Morra, Agostino Tafuri, Franca Falzetti, Francesco Cavazzini, P. Galieni, Marzia Salvucci, F. Rodighiero, Stefana Impera, Fausto Dore, P. De Fabritiis, V. Meneghini, Elisabetta Calistri, Paolo Vigneri, Ivana Pierri, Michele Cavo, Massimo Pini, Fabrizio Ciccone, Domenico Russo, E Trabacchi, Franco Gherlinzoni, Michele Baccarani, Ilaria Iacobucci, Roberto Sartori, Paolo Avanzini, D. Noli, Roberto Marasca, Simonetta Pardini, A. Malpignano, Maria Concetta Petti, Bruno Martino, M. Bergamaschi, Giovanni Pizzolo, Valeria Santini, E Orlandi, Catia Bigazzi, Serena Rupoli, Giuseppe Saglio, I. Cervello, Clementina Caracciolo, Anna Merli, R. Di Lorenzo, Enrico Pogliani, Francesco Lanza, Mariella Girasoli, M. Apolinari, Caterina Musolino, Francesco Fabbiano, D. Vallisa, Mario Annunziata, Gabriele Gugliotta, V. De Stefano, Ignazio Majolino, Sergio Storti, P. Leoni, Adele Capucci, Massimo Breccia, Alessandro Isidori, Carmen Fava, Gianni Binotto, Carlo Gambacorti-Passerini, L. Pacilli, Mario Tiribelli, Luciano Levato, Felicetto Ferrara, N. Di Renzo, Anna D'Emilio, Francesco Pisani, Fabio Stagno, Monica Crugnola, M. Trawiska, Patrizia Pregno, Marzia Defina, Stefano Molica, Mario Luppi, Michele Malagola, Davide Rapezzi, A. M. Liberati, E. De Biasi, A. Iurlo, Umberto Vitolo, Silvana Capalbo, Maria Teresa Bochicchio, F. Di Raimondo, Franco Aversa, Giuseppe Visani, Fausto Palmieri, Alessandro Rambaldi, Sergio Siragusa, Massimiliano Bonifacio, Luigiana Luciano, Giorgina Specchia, Elisabetta Abruzzese, A. De Blasio, Francesco Albano, Antonio Cuneo, Emilio Usala, Alfonso Zaccaria, R Fanin, Francesca Palandri, Fabrizio Pane, Enrico Montefusco, A. Gozzini, Giulio Rossi, Emanuele Angelucci, A. Bacigalupo, Marco Gobbi, Michele Cedrone

BACKGROUND: The incidence of chronic myeloid leukemia (CML) increases with age, but it is unclear how the characteristics of the disease vary with age. In children, where CML is very rare, it presents with more aggressive features, including huge spl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03825110771412a534fa417f8a805790
http://hdl.handle.net/2158/1046242

Zobrazit plný text záznamu

Anagrelide in Essential Thrombocythemia: A Retrospective Analysis of 220 Patients. Session Type: Poster Session 646-III

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3674::90bfe8c621d2487312917f3e9ae17c5a
https://hdl.handle.net/11380/619561

Zobrazit plný text záznamu

C3-Mediated Extravascular Hemolysis as Additional Mechanism of Disease in Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated by the Complent Inhibitor Eculizumab

Publikováno v: Blood. 112:485-485

PNH is a hematological disorder characterized by complement-mediated intravascular hemolysis due to lack on RBCs of the complement regulators CD55 and CD59 and subsequent activation of the membrane attack complex (MAC). Eculizumab (EC) is an anti-com

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::aa4510e33f6c9614e68cbbb3e9cc818d
https://doi.org/10.1182/blood.v112.11.485.485

Zobrazit plný text záznamu

Impact of Age in the Outcome of Patients with Chronic Myeloid Leukemia in Late Chronic Phase: Clinical and Molecular Results of a Phase II Study of the GIMEMA CML Working Party

Autor: Michele Baccarani, Marilina Amabile, Ilaria Iacobucci, Roberto Latagliata, Giuliana Alimena, Giuseppe Saglio, Fausto Castagnetti, Fabrizio Pane, Simona Soverini, Franco Iuliano, Gianantonio Rosti, Simona Bassi, Nicoletta Testoni, Giovanna Rege-Cambrin, Giovanni Martinelli, Francesca Palandri, Daniela Cilloni, Angela Poerio

Publikováno v: Web of Science

To assess the effect of age on response and compliance we performed a sub-analysis within a phase II trial of the GIMEMA CMLWorking Party (CML/002/STI571). Since the WHO cut-off age to define an older patient is 65 years, we identified: 226/284 (80%)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdc2feb55df02ae8b72b3a147d66cafb
https://doi.org/10.1182/blood.v108.11.4805.4805

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání